Walking in the Patient's Shoes
Takeda a Japanese company started in 1781 now with a global reach is showing other pharmaceutical companies the path towards increased patient focus with their groundbreaking immersive employee...
View ArticleEnterome Appoints Christophe Bonny as Chief Scientific Officer
PARIS and CAMBRIDGE Massachusetts November 3 2016 PRNewswire ENTEROME Bioscience SA a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome is pleased to announce...
View ArticleJanssen to Present Data Across Broad Rheumatology Portfolio and Immunology...
HORSHAM Pa. Nov. 3 2016 PRNewswire Janssen Biotech Inc. announced today that 28 abstracts will be presented at the 2016 American College of Rheumatology ACR Annual Meeting taking place in Washington...
View ArticleEisai and Arena Pharmaceuticals Announce Presentation of BELVIQÂ lorcaserin...
WOODCLIFF LAKE N.J. and SAN DIEGO Nov. 3 2016 PRNewswire Eisai Inc. and Arena Pharmaceuticals Inc. NASDAQ ARNA announced today the presentation of one oral presentation and one poster at Obesity WeekSM...
View ArticleRedHill Biopharma Provides Update on Ongoing Phase III and Phase II studies...
Topline results from both the ongoing Phase III clinical study for acute gastroenteritis and gastritis and the ongoing Phase II clinical study for diarrheapredominant irritable bowel syndrome IBSD are...
View ArticleNektar Therapeutics Reports Financial Results for the Third Quarter of 2016
SAN FRANCISCO Nov. 3 2016 PRNewswire Nektar Therapeutics Nasdaq NKTR today reported its financial results for the third quarter ended September 30 2016. Cash and investments in marketable securities at...
View ArticleArena Pharmaceuticals Reports Third Quarter 2016 Financial Results and...
SAN DIEGO Nov. 7 2016 PRNewswire Arena Pharmaceuticals Inc. Nasdaq ARNA today reported financial results for the third quarter ended September 30 2016 and provided a corporate update. "This was a...
View ArticleCommon Food Additive Promotes Colon Cancer in Mice
Emulsifiers which are added to most processed foods to aid texture and extend shelf life can alter intestinal bacteria in a manner that promotes intestinal inflammation and colorectal cancer according...
View ArticleNew Paradigms in Inflammatory Bowel Disease Management FREE
A review of the most recent principles guiding proper care of patients with Crohn disease and ulcerative colitis
View ArticleFirst Harvest Financial Analyzes Impact of Cannabis in November Election
TAMPA Fla. Nov. 8 2016 PRNewswire As Election Day nears First Harvest Financial recognizes the importance of keeping voters informed and educated on ballot issues particularly Amendment 2 and other...
View ArticleEsperite N.V. Stem Cells Genetic Tests and Pharmaceuticals
ÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂ ÂÂÂ ÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂ ESPERITE N.V. Stem Cells Genetic Tests and Pharmaceuticals Patent granted to Cell Factory in Europe confirms great...
View ArticleInflammatory Bowel Disease More Common than Previously Thought
A recent report reveals that Crohns disease and ulcerative colitis collectively known as inflammatory bowel disease IBD effect an estimated 3.1 million 1.3 U.S. adults. This is an increase from a...
View ArticleStanford Microbiome Pioneer Elisabeth Bik Becomes New Science Editor at uBiome
Microbial genomics leader uBiome has appointed its first fulltime Science Editor Dr. Elisabeth Bik who joins the fastgrowing company from Stanford University School of Medicine. Dr. Bik will continue...
View ArticlePromising transport molecule for steroid medications discovered
When the word steroids comes up a lot of people think of doping. It is much less well known that steroids are used in the treatment of many diseases such as asthma neurodermatitis multiple sclerosis...
View ArticleArena Pharmaceuticals Announces Poster at the American Heart Association AHA...
SAN DIEGO Nov. 9 2016 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced that Professor Lucie Clapp will present a poster at the American Heart Association AHA Scientific Sessions 2016...
View ArticleNektar Therapeutics Presents New Clinical Data from Ongoing Phase 1...
SAN FRANCISCO Nov. 9 2016 PRNewswire Nektar Therapeutics Nasdaq NKTR today announced that new Phase 1 clinical data for Nektar's lead immunooncology agent NKTR214 were presented at the SITC 2016 Annual...
View ArticleArena Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare...
SAN DIEGO Nov. 9 2016 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced that Amit Munshi the Company's President and Chief Executive Officer will present a corporate overview at the...
View ArticleSoligenix Announces Recent Accomplishments and Third Quarter 2016 Financial...
PRINCETON N.J. Nov. 10 2016 PRNewswire Soligenix Inc. OTCQB SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases...
View ArticleBiosimilars of natalizumab
Natalizumab is a humanized monoclonal antibody against the cell adhesion molecule 4integrin. Natalizumab is believed to work by reducing the ability of inflammatory immune cells to attach to and pass...
View ArticleUCB showcases advancements in its late stage immunology portfolio through...
ATLANTA Nov. 11 2016 PRNewswire UCB a global biopharmaceutical company focusing on immunology neurology and bone treatments and research is proud to announce 16 CIMZIAÂ certolizumab pegol presentations...
View Article